{
  "id": 20602134,
  "title": "Have $1,000? This Beaten-Down Biotech Has 4 Phase 3 Obesity Trials Underway.",
  "url": "https://urgent.news/2026/11/18/have-1-000-this-beaten-down-biotech-has-4-phase-3-obesity-trials-20602134",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-18T13:20:02.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/have-1000-beaten-down-biotech-has-4-phase-3-obesity-trials-underway"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsViking Therapeutics has four phase 3 obesity trials underway for VK2735.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Have $1,000? This Beaten-Down Biotech Has 4 Phase 3 Obesity Trials Underway.",
        "url": "https://urgent.news/2026/11/18/have-1-000-this-beaten-down-biotech-has-4-phase-3-obesity-trials",
        "published": "2026-11-18T13:00:02.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}